Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Calgary

$135,000.00

The Chemo-Gut Trial: A double-blind randomized controlled trial investigating the effects of a multi-strain probiotic on gut microbiota, gastrointestinal symptoms, and psychosocial health in cancer survivors

EF 2022-23

Résumé
Background: For select cancers (e.g. leukemia, breast) 5-year survival rates range from 61 - 89% but many survivors will experience chronic symptoms after treatment ends. Our previous work shows that 52% of survivors experience moderate to severe gastrointestinal (GI) symptoms for up to 2.5 years post-treatment, reduced gut microbial diversity and poor mental health. Probiotics may help restore gut health and reduce symptoms after cancer, but no studies have looked at this. Our study will be the first to determine whether probiotics can reduce GI and psychosocial symptoms in cancer survivors by impacting the gut microbiome. My aim is to investigate the effects of a multi-strain probiotic versus placebo on GI and psychological well-being. Methods: This trial will recruit 66 participants who will be randomized to the probiotic or placebo group for a 12-week trial. Adult survivors diagnosed with a solid tumour or blood cancer who completed chemotherapy in <5 years, and show elevated GI or psychosocial symptoms will be included. The probiotic capsule will contain important bacterial strains to be ingested orally twice daily. Stool samples will be collected, and GI and psychosocial surveys will be completed. Implications: Understanding how to improve GI and psychological symptoms of cancer survivors may have implications for aftercare protocols. My findings will further enable patients to better manage their symptoms and make informed decisions about their health. I will produce patient materials (e.g. infographics, personal results summary) to ensure patients have the knowledge necessary to promote their health.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
472129
Name
Deleemans Julie
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
The Chemo-Gut Trial: A double-blind randomized controlled trial investigating the effects of a multi-strain probiotic on gut microbiota, gastrointestinal symptoms, and psychosocial health in cancer survivors
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer Survivorship; Gastrointestinal Health; Gut Microbiota; Patient Reported Outcomes; Probiotics; Psychosocial Health
Abstract
Background: For select cancers (e.g. leukemia, breast) 5-year survival rates range from 61 - 89% but many survivors will experience chronic symptoms after treatment ends. Our previous work shows that 52% of survivors experience moderate to severe gastrointestinal (GI) symptoms for up to 2.5 years post-treatment, reduced gut microbial diversity and poor mental health. Probiotics may help restore gut health and reduce symptoms after cancer, but no studies have looked at this. Our study will be the first to determine whether probiotics can reduce GI and psychosocial symptoms in cancer survivors by impacting the gut microbiome. My aim is to investigate the effects of a multi-strain probiotic versus placebo on GI and psychological well-being. Methods: This trial will recruit 66 participants who will be randomized to the probiotic or placebo group for a 12-week trial. Adult survivors diagnosed with a solid tumour or blood cancer who completed chemotherapy in <5 years, and show elevated GI or psychosocial symptoms will be included. The probiotic capsule will contain important bacterial strains to be ingested orally twice daily. Stool samples will be collected, and GI and psychosocial surveys will be completed. Implications: Understanding how to improve GI and psychological symptoms of cancer survivors may have implications for aftercare protocols. My findings will further enable patients to better manage their symptoms and make informed decisions about their health. I will produce patient materials (e.g. infographics, personal results summary) to ensure patients have the knowledge necessary to promote their health.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Deleemans, Julie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~